The INTERCEPT™ Blood System is intended for the preparation and storage of donated platelets and plasma in order to reduce the risk of transfusion-transmitted infection, including sepsis, and to potentially reduce allergic reactions and the risk of transfusion-associated graft versus host disease (TA-GVHD). With INTERCEPT, blood centres and hospitals can efficiently and proactively control the safety of their blood supply.